These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3017905)

  • 1. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.
    Urtasun RC; Chapman JD; Raleigh JA; Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1263-7. PubMed ID: 3017905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel technique for measuring human tissue pO2 at the cellular level.
    Urtasun RC; Koch CJ; Franko AJ; Raleigh JA; Chapman JD
    Br J Cancer; 1986 Sep; 54(3):453-7. PubMed ID: 3756081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole and other hypoxia markers: metabolism and applications.
    Franko AJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1195-202. PubMed ID: 3528089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.
    Hoffman JM; Rasey JS; Spence AM; Shaw DW; Krohn KA
    Stroke; 1987; 18(1):168-76. PubMed ID: 3810750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.
    Parliament MB; Franko AJ; Allalunis-Turner MJ; Mielke BW; Santos CL; Wolokoff BG; Mercer JR
    Br J Cancer; 1997; 75(3):311-8. PubMed ID: 9020473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-misonidazole labeling and viability of hypoxic cells in the sandwich system, an in vitro tumor analogue.
    Hlatky L; Ring CS; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):143-53. PubMed ID: 2912936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
    Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
    Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole.
    Shalinsky DR; McNamara DB; Agrawal KC
    Cancer Res; 1989 Jul; 49(14):3853-6. PubMed ID: 2736527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
    Huang T; Civelek AC; Li J; Jiang H; Ng CK; Postel GC; Shen B; Li XF
    J Nucl Med; 2012 Aug; 53(8):1262-8. PubMed ID: 22717978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding.
    Kim IH; Lemmon MJ; Brown JM
    Radiat Res; 1993 Sep; 135(3):411-7. PubMed ID: 8378534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro.
    Franko AJ; Koch CJ; Garrecht BM; Sharplin J; Hughes D
    Cancer Res; 1987 Oct; 47(20):5367-76. PubMed ID: 3652041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG; Hazlehurst JL; Brown JM
    Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydralazine does not increase hypoxia in tumors growing in preirradiated tissue.
    Lemmon MJ; Brown JM
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1435-40. PubMed ID: 1938551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids.
    Gross MW; Karbach U; Groebe K; Franko AJ; Mueller-Klieser W
    Int J Cancer; 1995 May; 61(4):567-73. PubMed ID: 7759162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro determination of thymidine-3H labeling index in human solid tumors.
    Livingston RB; Ambus U; George SL; Freireich EJ; Hart JS
    Cancer Res; 1974 Jun; 34(6):1376-80. PubMed ID: 4363655
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors.
    Chapman JD; McPhee MS; Walz N; Chetner MP; Stobbe CC; Soderlind K; Arnfield M; Meeker BE; Trimble L; Allen PS
    J Natl Cancer Inst; 1991 Nov; 83(22):1650-9. PubMed ID: 1749018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.